Stroke Drugs: Medicare Part D Spending

What Medicare Part D spent on the medicines used for this topic, how many people used them, and the cost per unit.

Each number has its full source under its own list below.

Medicare Part D spending

10 medicines (calendar year 2024). Medicines whose FDA label lists a use on this topic, by what Part D spent on them in total. Many medicines have more than one use, so the totals are not added up.

At the source
  1. 1EliquisApixaban · $9.64 per unit$20.8 billion
  2. 2Atorvastatin CalciumAtorvastatin Calcium · $0.15 per unit$756.5 million
  3. 3Rosuvastatin CalciumRosuvastatin Calcium · $0.19 per unit$436.6 million
  4. 4SimvastatinSimvastatin · $0.11 per unit$126.4 million
  5. 5CrestorRosuvastatin Calcium · $8.79 per unit$31.9 million
  6. 6LipitorAtorvastatin Calcium · $15.71 per unit$26.8 million
  7. 7ZocorSimvastatin · $8.10 per unit$1.6 million
  8. 8AtorvaliqAtorvastatin Calcium · $1.22 per unit$932,042
  9. 9Ezallor SprinkleRosuvastatin Calcium · $3.21 per unit$5,987
  10. 10FlolipidSimvastatin · $1.70 per unit$3,309

Source: Centers for Medicare & Medicaid Services, Medicare Part D Spending by Drug, calendar year 2024. Retrieved 12 Nov 2026.

Benchmarks on stroke

Countries side by side on public measures for this topic.

All benchmarks

US drug spending on related topics

All topics

Acuitas market sizes and forecasts are only in our full reports. How we use public data.